Home
Quick search

Press Releases

2014-04-08
Notice of Annual General Meeting
Kallelse till årsstämma
2014-02-20
Year End Report 2013
Affibody Medical AB (publ) (“Affibody” or “the Company”), a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™, today issued its Full Year Report for 2013.

Follow Affibody